Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hypertension, Portal 1Carcinoma, Hepatocellular 1

Interventions

Liver Transplantation 1Diagnostic Imaging 1Carvedilol 16-acetylaminocaproic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hypertension, Portal × 6-acetylaminocaproic acid × Clear all
NCT06434753 2024-06-04

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡